News Conference News TCT 2021 OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions L.A. McKeown October 25, 2021
News Conference News TCT 2021 EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI Michael O'Riordan October 15, 2021
News Daily News Cardiac Deaths and Adverse Events After PCI Have Declined With Time L.A. McKeown October 05, 2021
News Daily News DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry Caitlin E. Cox September 15, 2021
News Conference News In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS Shelley Wood August 30, 2021
News Daily News DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2 L.A. McKeown August 16, 2021
News Daily News FDA Permits 28-Day DAPT in Xience-Treated Patients at High Bleeding Risk Michael O'Riordan June 30, 2021
News Conference News EuroPCR 2021 Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate Caitlin E. Cox May 24, 2021
News Conference News EuroPCR 2021 FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold Michael O'Riordan May 19, 2021
News Conference News EuroPCR 2021 The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages L.A. McKeown May 19, 2021
News Daily News Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients Shelley Wood April 06, 2021
News Daily News CRT 2021 COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold Michael O'Riordan March 17, 2021
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Daily News No Harm, No Help With Bioabsorbable-Polymer Stents: Registry Michael O'Riordan March 01, 2021